Excel Industries Share Price
Sector: Chemical Manufacturing
1111.00 -28.70 (-2.52%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1106.05
Today’s High
1152.15
52 Week Low
798.50
52 Week High
1745.00
1115.90 -23.00 (-2.02%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1104.10
Today’s High
1154.80
52 Week Low
799.10
52 Week High
1760.00
Key Metrics
- Market Cap (In Cr) 1396.61
- Beta 0.72
- Div. Yield (%) 1.21
- P/B 0.9
- TTM P/E 14.3
- Peg Ratio -0.88
- Sector P/E 17.01
- D/E 0
- Open Price 1135
- Prev Close 1139.7
Excel Industries Analysis
Price Analysis
-
1 Week0.73%
-
3 Months30.06%
-
6 Month-26.62%
-
YTD-10.96%
-
1 Year10.41%
Risk Meter
- 59% Low risk
- 59% Moderate risk
- 59% Balanced Risk
- 59% High risk
- 59% Extreme risk
Excel Industries News
Q4 results today: Tata Power, Eicher Motors, Lupin, Shree Cements on May 14
1 min read . 14 May 2025Inclusive Leadership: How the finest workplaces drive growth and diversity
5 min read . 05 Dec 2024Honouring Visionaries: The Chiratae Ventures Patrick J. McGovern Awards
1 min read . 23 Oct 2024PwC India and Meta partner to develop enterprise-grade GenAI Solutions
1 min read . 03 Oct 2024Excel Industries Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 978.07
- Selling/ General/ Admin Expenses Total
- 121.8
- Depreciation/ Amortization
- 34.07
- Other Operating Expenses Total
- 230.47
- Total Operating Expense
- 892.57
- Operating Income
- 85.5
- Net Income Before Taxes
- 112.94
- Net Income
- 85.31
- Diluted Normalized EPS
- 67.87
- Period
- 2025
- Total Assets
- 1920.4
- Total Liabilities
- 331.69
- Total Equity
- 1588.72
- Tangible Book Valueper Share Common Eq
- 1244.71
- Period
- 2025
- Cashfrom Operating Activities
- 61.82
- Cashfrom Investing Activities
- -41.29
- Cashfrom Financing Activities
- -16.07
- Net Changein Cash
- 4.46
- Period
- 2024
- Total Revenue
- 826.14
- Selling/ General/ Admin Expenses Total
- 208.28
- Depreciation/ Amortization
- 31.41
- Other Operating Expenses Total
- 13.86
- Total Operating Expense
- 831.55
- Operating Income
- -5.41
- Net Income Before Taxes
- 22.65
- Net Income
- 17.01
- Diluted Normalized EPS
- 14.04
- Period
- 2024
- Total Assets
- 1795.53
- Total Liabilities
- 368.47
- Total Equity
- 1427.06
- Tangible Book Valueper Share Common Eq
- 1119.65
- Period
- 2024
- Cashfrom Operating Activities
- 72.37
- Cashfrom Investing Activities
- -51.23
- Cashfrom Financing Activities
- -16.93
- Net Changein Cash
- 4.21
- Period
- 2023
- Total Revenue
- 1089.82
- Selling/ General/ Admin Expenses Total
- 230.02
- Depreciation/ Amortization
- 31.34
- Other Operating Expenses Total
- 15.25
- Total Operating Expense
- 990.5
- Operating Income
- 99.32
- Net Income Before Taxes
- 105.77
- Net Income
- 79.94
- Diluted Normalized EPS
- 64.73
- Period
- 2023
- Total Assets
- 1492.58
- Total Liabilities
- 250.83
- Total Equity
- 1241.75
- Tangible Book Valueper Share Common Eq
- 972.57
- Period
- 2023
- Cashfrom Operating Activities
- 125.35
- Cashfrom Investing Activities
- -117.5
- Cashfrom Financing Activities
- -34.58
- Net Changein Cash
- -26.74
- Period
- 2022
- Total Revenue
- 1178.02
- Selling/ General/ Admin Expenses Total
- 245.41
- Depreciation/ Amortization
- 30.64
- Other Operating Expenses Total
- 14.43
- Total Operating Expense
- 976.92
- Operating Income
- 201.1
- Net Income Before Taxes
- 213.45
- Net Income
- 161.2
- Diluted Normalized EPS
- 128.42
- Period
- 2022
- Total Assets
- 1486.65
- Total Liabilities
- 337.3
- Total Equity
- 1149.35
- Tangible Book Valueper Share Common Eq
- 899.04
- Period
- 2022
- Cashfrom Operating Activities
- 108.93
- Cashfrom Investing Activities
- -104.09
- Cashfrom Financing Activities
- -16.89
- Net Changein Cash
- -12.04
- Period
- 2021
- Total Revenue
- 749.47
- Selling/ General/ Admin Expenses Total
- 187.8
- Depreciation/ Amortization
- 27.13
- Other Operating Expenses Total
- 11.26
- Total Operating Expense
- 653.36
- Operating Income
- 96.1
- Net Income Before Taxes
- 100.81
- Net Income
- 71.09
- Diluted Normalized EPS
- 56
- Period
- 2021
- Total Assets
- 1111.15
- Total Liabilities
- 259.61
- Total Equity
- 851.54
- Tangible Book Valueper Share Common Eq
- 662.14
- Period
- 2021
- Cashfrom Operating Activities
- 90.86
- Cashfrom Investing Activities
- -52.6
- Cashfrom Financing Activities
- -16.83
- Net Changein Cash
- 21.42
- Period
- 2020
- Total Revenue
- 702.48
- Selling/ General/ Admin Expenses Total
- 188.9
- Depreciation/ Amortization
- 22.75
- Other Operating Expenses Total
- -0.56
- Total Operating Expense
- 594.73
- Operating Income
- 107.75
- Net Income Before Taxes
- 114.91
- Net Income
- 96.07
- Diluted Normalized EPS
- 76.71
- Period
- 2020
- Total Assets
- 937.35
- Total Liabilities
- 236.46
- Total Equity
- 700.89
- Tangible Book Valueper Share Common Eq
- 541.95
- Period
- 2020
- Cashfrom Operating Activities
- 110.18
- Cashfrom Investing Activities
- -61.38
- Cashfrom Financing Activities
- -31.46
- Net Changein Cash
- 17.33
- Period
- 2019
- Total Revenue
- 824.96
- Selling/ General/ Admin Expenses Total
- 176
- Depreciation/ Amortization
- 18.09
- Other Operating Expenses Total
- -0.55
- Total Operating Expense
- 593.03
- Operating Income
- 231.93
- Net Income Before Taxes
- 234.21
- Net Income
- 153.45
- Diluted Normalized EPS
- 122.4
- Period
- 2019
- Total Assets
- 915.7
- Total Liabilities
- 216.13
- Total Equity
- 699.56
- Tangible Book Valueper Share Common Eq
- 556.08
- Period
- 2019
- Cashfrom Operating Activities
- 135.16
- Cashfrom Investing Activities
- -111.21
- Cashfrom Financing Activities
- -24.39
- Net Changein Cash
- -0.45
- Period
- 2025-03-31
- Total Revenue
- 247.84
- Selling/ General/ Admin Expenses Total
- 32.79
- Depreciation/ Amortization
- 8.76
- Other Operating Expenses Total
- 59.59
- Total Operating Expense
- 237.03
- Operating Income
- 10.81
- Net Income Before Taxes
- 16.29
- Net Income
- 12.41
- Diluted Normalized EPS
- 9.87
- Period
- 2025-03-31
- Total Assets
- 1920.4
- Total Liabilities
- 331.69
- Total Equity
- 1588.72
- Tangible Book Valueper Share Common Eq
- 1244.71
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 61.82
- Cashfrom Investing Activities
- -41.29
- Cashfrom Financing Activities
- -16.07
- Net Changein Cash
- 4.46
- Period
- 2024-12-31
- Total Revenue
- 196.41
- Selling/ General/ Admin Expenses Total
- 28.72
- Depreciation/ Amortization
- 8.53
- Other Operating Expenses Total
- 53.05
- Total Operating Expense
- 192.86
- Operating Income
- 3.55
- Net Income Before Taxes
- 8.41
- Net Income
- 6.2
- Diluted Normalized EPS
- 4.93
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 268.91
- Selling/ General/ Admin Expenses Total
- 31.35
- Depreciation/ Amortization
- 8.67
- Other Operating Expenses Total
- 58.75
- Total Operating Expense
- 228.61
- Operating Income
- 40.3
- Net Income Before Taxes
- 47.13
- Net Income
- 35.68
- Diluted Normalized EPS
- 28.39
- Period
- 2024-09-30
- Total Assets
- 1987.16
- Total Liabilities
- 396.54
- Total Equity
- 1590.62
- Tangible Book Valueper Share Common Eq
- 1249.14
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 49.94
- Cashfrom Investing Activities
- -35.32
- Cashfrom Financing Activities
- -12.14
- Net Changein Cash
- 2.48
- Period
- 2024-06-30
- Total Revenue
- 264.91
- Selling/ General/ Admin Expenses Total
- 28.95
- Depreciation/ Amortization
- 8.11
- Other Operating Expenses Total
- 59.08
- Total Operating Expense
- 234.06
- Operating Income
- 30.85
- Net Income Before Taxes
- 41.12
- Net Income
- 31.02
- Diluted Normalized EPS
- 24.68
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 233.54
- Selling/ General/ Admin Expenses Total
- 26.78
- Depreciation/ Amortization
- 7.98
- Other Operating Expenses Total
- 55.37
- Total Operating Expense
- 228.9
- Operating Income
- 4.63
- Net Income Before Taxes
- 8.9
- Net Income
- 6.67
- Diluted Normalized EPS
- 5.31
- Period
- 2024-03-31
- Total Assets
- 1795.53
- Total Liabilities
- 368.47
- Total Equity
- 1427.06
- Tangible Book Valueper Share Common Eq
- 1119.65
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 72.37
- Cashfrom Investing Activities
- -51.23
- Cashfrom Financing Activities
- -16.93
- Net Changein Cash
- 4.21
- Period
- 2023-12-31
- Total Revenue
- 180.28
- Selling/ General/ Admin Expenses Total
- 27.41
- Depreciation/ Amortization
- 7.85
- Other Operating Expenses Total
- 45.83
- Total Operating Expense
- 186.47
- Operating Income
- -6.19
- Net Income Before Taxes
- 4.09
- Net Income
- 2.68
- Diluted Normalized EPS
- 2.13
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Excel Industries Technical
Moving Average
SMA
- 5 Day1160.14
- 10 Day1096.29
- 20 Day1095.83
- 50 Day1018.27
- 100 Day1098.97
- 300 Day1297.32
Excel Industries Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Ultramarine And Pigments
- 540
- 1.35
- 0.25
- 601.2
- 375.25
- 1570.14
- Agarwal Industrial Corporation
- 1036.45
- -3.45
- -0.33
- 1383.15
- 787.7
- 1538.75
- Excel Industries
- 1111
- -28.7
- -2.52
- 1745
- 798.5
- 1396.61
- 3b Blackbio Dx
- 1697.2
- 3.55
- 0.21
- 2350
- 765
- 1460.73
- Astec Lifesciences
- 698
- -13.3
- -1.87
- 1487.65
- 635.95
- 1368.22
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Ultramarine And Pigments
- 27.38
- 1.76
- 9.99
- 13.49
- Agarwal Industrial Corporation
- 14.34
- 3.06
- 24.11
- 4.46
- Excel Industries
- 17.28
- 0.93
- 7.13
- 8.6
- 3b Blackbio Dx
- 45.37
- 6.54
- 33.47
- 44.85
- Astec Lifesciences
- -
- 6.1
- -0.07
- -0.04
Excel Industries Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 14-May-25
- Audited Results & Final Dividend
- 07-Feb-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 09-Aug-24
- Quarterly Results
- 24-May-24
- Audited Results & Final Dividend
- 09-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- 16-May-23
- Audited Results & Final Dividend
- 10-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 21-Aug-25
- 14-May-25
- AGM
- 19-Sept-24
- 09-Aug-24
- AGM
- 14-Sept-23
- 11-Aug-23
- AGM
- 23-Sept-22
- 09-Aug-22
- AGM
- 23-May-22
- 21-Apr-22
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 14-May-25
- 14-Aug-25
- -
- 13.75
- 24-May-24
- 12-Sept-24
- 12-Sept-24
- 5.5
- 16-May-23
- 07-Sept-23
- 07-Sept-23
- 11.25
- 28-May-21
- -
- 16-Sept-21
- 11.25


